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Abstract: 
Counterfeit and illegal pharmaceutical products are an increasing worldwide problem and 
constitute a major challenge for analytical laboratories to detect and characterize them. 
Spectroscopic techniques as infrared spectroscopy and Raman spectroscopy were always the 
first methods of choice to detect counterfeits and illegal preparations, but due to the evolution 
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1. Introduction 
Counterfeiting of medicinal products is a problem that exists since centuries. During the first 
century of our era, Pedanius Dioscorides, a Greek physician, warned already about the 
dangers of adulterated drugs [1]. Since then many crises of falsification of medicines have 
been documented [2]. Most of these crises implicated falsified herbal medicines and resulted 
in many lethal accidents, due to a lack of efficacy and/or toxicity of the adulterated drugs. 
In modern times the counterfeiting of drugs is a growing problem for already several years, 
especially since the extension of the internet. It is estimated that counterfeit drugs represent 
7% of the worldwide pharmaceutical market [3,4]. Africa, South East Asia and many 
countries in Latin America are the most affected areas, where the World Health Organisation 
estimates that more than 30% of the medicines on sale are counterfeited [5]. The 
industrialized countries (USA, EU, Australia, Canada, Japan and New-Zealand) have 
approximately 1% of their pharmaceutical market affected despite the effective regulatory 
systems and market controls.  
According to data of the Pharmaceutical Security Institute (PSI), the international trade of 
counterfeit medicines is in permanent growth [6]. Figure 1 shows the total number of reports 
of counterfeiting over the past nine years, revealing a permanent increase of the number of 
cases. Many factors may explain this growth, among others: the lack of effective enforcement 
agencies in developing countries and the lack of a harmonised legal framework to define 
pharmaceutical crime and the penalties to apply. There is more and more evidence that the 
trade in counterfeit drugs is linked to international organised crime, since the trade of 
counterfeit drugs is more lucrative than the trade in narcotics and the criminal penalties for 
pharmaceutical counterfeiting are less severe [7,8]. The growth concerning the counterfeiting 
of medicines is also shown by the evolution of the number of cases opened by the FDA’s 
office of criminal investigations (Figure 2) [9].  
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The World Health Organisation (WHO) first cited the counterfeiting of medicines in 1985 at 
the conference of experts on the rational use of drugs in Nairobi. In 1988, a World Health 
Assembly Resolution (41.16) recommended to “initiate programmes for the prevention and 
detection of export, import and smuggling of falsely labelled, spurious, counterfeited or 
substandard pharmaceutical preparations” [10]. This led to the launch of many international 
initiatives among which the International Medicinal Products Anti-Counterfeiting Taskforce 
(IMPACT) started by the WHO in 2006. In parallel, the major pharmaceutical companies 
established the PSI in 2002. On the European level the European Alliance for Access to Safe 
Medicines (EAASM) was created [11]. This is a pan-european patient safety initiative 
committed to promoting the exclusion of counterfeit and substandard medicines from the 
supply chain. The European Parliament and the Council of Europe created recently an 
amendment to the European directive 2001/83/EC [12] on the community code relating to 
medicinal products for human use, describing the policy of the European Union towards 
counterfeit and substandard medicines. On the 26
th
 of October 2011 Europe launched the 
Medicrime convention which was held in Moscow, Russia. Medicrime is the first 
international instrument for the criminalisation of counterfeiting of medical products and 
similar crimes in order to protect public health [13]. 
The WHO [14] defines a counterfeit drug as: “one which is deliberately and fraudulently 
mislabelled with respect to identity and/or source. Counterfeiting can apply to both branded 
and generic products and counterfeit products may include products with the correct 
ingredients or with the wrong ingredients, without the active ingredients, with insufficient 
active ingredient or with fake packaging.” Next to this definition the WHO also defines a 
substandard medicine (also called, out of specification (OOS) products) as: “a genuine 
medicine produced by manufacturers authorized by the National Medical Regulatory 
Authority which do not meet the quality specifications set for them by national standards”. By 
 4 
definition the latter group of medicines should not be present on the market. If they are, a 
problem occurred with the controls of the legitimate supply chain or there have been 
unscrupulous activities and reselling of medicines to be destroyed [10].  
The European parliament recently adopted a definition of “falsified medicines” that is a 
compromise between the counterfeit and substandard medicines definition of the WHO: “A 
falsified medicinal product is any medicinal product with a false representation of: (a) its 
identity, including its packaging and labelling, name, composition in respect of any of its 
components including excipients and strength; and/or (b) its source, including the 
manufacturer, country of manufacturing, country of origin, marketing authorization holder; 
and/or (c) its history, including the records and documents relating to the distribution channels 
used [15].”    
US law defines counterfeit drugs “as these sold under a product name without proper 
authorization. Counterfeiting can apply to both brand name and generic products, where the 
identity of the source is deliberately and fraudulently mislabelled in a way that suggests it is 
the authentic approved product. Counterfeit products may include products without the active 
ingredient, with an insufficient quantity of the active ingredient, with the wrong active 
ingredient, or with fake packaging [4].” 
Due to the fact that the above mentioned definitions are quite general and not always adapted 
to the situation encountered on the European and the other markets of the industrialised 
world, the Dutch National Institute for Public Health and the Environment (RIVM) proposed 
a classification (table 1) distinguishing counterfeits, which appearance corresponds to the one 
of the genuine products, and imitations, which do not [16]. Most of these imitations originate 
from Asian countries, who do not recognize European and American patents and represent the 
majority of illegal pharmaceutical preparations analysed in the Official Medicines Control 
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Laboratories (OMCL) recognised by the European Directorate For Quality of Medicines 
(EDQM).    
A recent study funded by Pfizer estimates the West-European illicit trade of medicines at € 
10.5 billions. This study states that one out of five Europeans has bought a prescription only 
medicine from an illegal source. Most of these bought their medicines on the internet. 
According to a WHO estimation, more than 50% of the medicines bought from websites 
disclosing their identity are counterfeited [17,18].  
Even if pharmaceutical counterfeiting is a global problem, the categories of adulterated drugs 
and the risks associated vary according to the region considered.  
In developing countries the “anti-infective” drugs are the most counterfeited [19]. This 
represents a serious public health problem, since most of the population buy their medicines 
in the street at low prices. These products are often counterfeited or substandard medicines 
with less or no therapeutic activity. When treating diseases associated with a high untreated 
mortality such as malaria, pneumonia, meningitis, AIDS, typhoid and tuberculosis with 
inefficient drugs, mortality and morbidity increase. Moreover, the use of subtherapeutic 
amounts of active ingredients increases the risk of developing microbial resistance. In this 
case, even genuine drugs could become inefficient [10].  
In industrialised countries the main therapeutic categories counterfeited are “lifestyle” drugs 
(weight loss drugs and potency enhancement drugs). The risks associated with these drugs are 
mostly due to the presence of toxic compounds or impurities, too high amounts of active 
ingredients, presence of unexpected active ingredients or new unknown designer molecules 
and wrong, missing or inadequate information concerning the use of the drug [20]. Other 
categories such as antineoplastic drugs or cardiovascular counterfeited drugs have also been 
detected [21]. The fact that counterfeit medicines may enter the legal supply chain represents 
a major risk for public health. Moreover, besides potential adverse effects, the patients may 
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loose trust in medicines even if they are sold in pharmacy and so damage their trust in the 
health care systems, the health care professional, the pharmaceutical industry and the Drug 
Regulatory Authorities [22].   
Another problem besides counterfeiting is the adulteration of herbal products. In the 
developed countries people buy herbal alternatives for the treatment of obesity or erectile 
dysfunction disorders via internet, believing that there is no risk for their health. Though, 
several studies detected synthetic drugs as adulterants in the herbal formulations, representing 
huge risks for public health [23,24]. When purchasing counterfeit drugs, the patient can be 
held partially responsible for the health risk he is willing to take, but this is not the case for 
adulterated herbal remedies. These products are fraudulently labelled and there is no way for 
the patient of knowing he is taking preparations representing high risks for his health.  
The national and international authorities have to be supported with data about the falsified 
samples from laboratory analysis. Therefore several laboratories throughout the world 
specialised themselves in the detection and analysis of counterfeit medicines. More 
knowledge about the samples can lead to a better fight against counterfeiting and a growing 
awareness of the risks by the patients.  
Several reviews have already been published in the domain of counterfeit medicines and 
illegal pharmaceutical preparations. Most of them focus on a specific technique e.g. Nuclear 
Magnetic Resonance (NMR) [25] or on a specific type of counterfeited products e.g. PDE-5 
inhibitors [26]. A few, more general reviews were published [4,27], in which the different 
techniques that could be applied in the analysis of counterfeit medicines were shortly 
discussed together with some applications. This review intends to give an updated overview 
of the techniques and approaches used in the detection and characterisation of counterfeit 
medicines and illegal pharmaceutical preparations, with a focus on the role of 
chromatography and the chromatographic approaches described in literature.  To our 
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knowledge no reviews were published in this domain focussing on chromatography. Though 
chromatographic and hyphenated techniques have high potential in the analysis and 
characterisation of counterfeit medicines and illegal pharmaceutical preparations, since they 
allow not only the detection and quantification of active ingredients but can also give a 
complete image of the composition of the sample. This characteristics made chromatography 
the number one technique for  risk evaluations of illegal preparations. 
 
2. Analytical approaches 
The fight against the counterfeiting of medicines resulted in numerous articles where several 
analytical techniques have already been used for the detection of counterfeit medicines. These 
techniques are separated in two main groups: chromatographic and spectroscopic techniques.  
 
2.1. Spectroscopic approaches: a brief overview 
Spectroscopic techniques are often preferred to chromatography for the identification of 
counterfeit drugs because of the fact that they are fast, need less (or no) sample preparation 
and some of them are non destructive. Fourier-transformed Infrared spectroscopy (FT-IR) 
[28-31], Near Infrared spectroscopy (NIR) [30, 32-36], Raman spectroscopy [30,33,37-41], 
X-ray diffraction (XRD) [42], colorimetry [43-47] and Nuclear Magnetic Resonance (NMR) 
[38,48,49] have demonstrated their usefulness to detect counterfeit or adulterated drugs. FT-
IR and NMR are often used in the structure elucidation of active compounds or novel 
analogues found in illegal pharmaceutical preparations [25,28,29,38,48,50-74]. In most cases 
these techniques are used in combination with liquid chromatography with mass spectrometry 
detection (see section 2.2.2.2). NIR at the contrary is more used in the detection and the 
screening of counterfeit medicines. This is shown for example by Vredenbregt et al. [32], who 
described a method for the screening of Viagra
®
 tablets (genuine, counterfeit and imitations) 
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which is able to check homogeneity of a batch, detect counterfeit tablets and imitations and 
reveal the presence of sildenafil citrate in the tablets.  Another example was given by Been et 
al. [33] who related the NIR spectra of counterfeit medicines to their chemical profile and 
discriminate in that way counterfeits and genuines, but also different categories of counterfeit 
medicines. Dowell et al. [34] could discriminate between genuine and counterfeit artesunate 
tablets based on their NIR spectrum and Da Silva Fernandes et al. [35] used NIR to detect 
glibenclamide adulteration in tablets in a non-destructive way. A final example was given by 
Storme-Paris et al. [36], who used NIR spectra and chemometrics to discriminate between 
authentic samples, suspicious samples (samples with the same batch number as the 
counterfeits, withdrawn as a precaution) and counterfeit or imitation samples. Raman 
spectroscopy was also used in the discrimination of counterfeit and genuine tablets 
[30,33,37,38]. This discrimination is based on the presence of different excipients which 
could also be identified with Raman spectroscopy as described by Trefi et al. [38]. Been et al. 
[33] and Dégardin et al. [40] related the Raman spectra to the chemical profiles of counterfeit 
medicines and were able to discriminate genuines from counterfeits and to differentiate 
between different categories of counterfeit medicines. Raman spectroscopy could also be used 
in portable devices to detect counterfeit medicines. An example of this for artesunate tablets 
was given by Ricci et al. [41]. Another approach, which is becoming more popular is the 
combination of different spectroscopic techniques for the detection and characterisation of 
potential counterfeited samples. An example of a general approach where two techniques are 
used next to each other is given by De Peinder et al. [75], who used NIR and Raman 
spectroscopy to discriminate between genuine and counterfeit tablets of Lipitor
®
. Sacré et al. 





 with FT-IR, NIR and Raman spectroscopy and showed that the data is 
complementory. In that way they were able to combine different spectra in to one data set and 
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treat is as a whole using chemometrics. The combination of different spectra improved the 
classification and predictive properties of the models, compared to the ones calculated based 
on only one type of spectrum [76]. The combination of these techniques in the fight against 
counterfeit of medicines is promising, since the quality of the counterfeit tablets is increasing 
[30,76]. Recently the use of Raman microscopy was also described for the discrimination 
between counterfeit and genuine products [39,77]. 
Even if NMR spectroscopy is often used in combination with MS and FT-IR for structure 
elucidation, NMR as such is also able to reveal differences in composition of tablets. As an 
example Holzgrabe et al. [25] used NMR to reveal differences in composition between 
genuine and counterfeit tablets of Viagra
®
. Nyadong et al. [49] applied NMR for the 
characterisation of 14 different artesunate preparations, representative for the informal Asian 
market. The results revealed that only five preparations contained the active ingredient. NMR 
is without any doubt a very valuable technique in counterfeit detection and analysis, though it 
has some disadvantages. Next to the fact that it necessitates expensive equipment, it also 
needs experienced scientists to operate it and to interpret the data, especially in the analysis of 
unknown samples. 
X-ray powder diffraction (XRPD), even if quite expensive and not present in a common 
laboratory for quality control of medicines, showed its usefulness. Maurin et al. [42] showed 
that XRPD enables a fast screening of tablets which is able to discriminate between 
counterfeit and genuine products as well as reveals differences in coating and product 
composition. Ortiz et al. [78] presented recently an application of X-ray Fluorescence 
spectrometry for the chemical profiling of sildenafil and tadalafil tablets. Based on these 
chemical profiles the authors were able to check the quality of the tablets as well as to detect 
suspicious samples. 
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Colorimetry is less used in the detection of counterfeits but can be useful to screen for the 
presence of an active ingredient and to quantitate it [43,45-47], even if in this case 
chromatographic methods seem more appropriate. Also the detection of counterfeit tablets 
based on colorimetric measurements of the tablets coatings or the secondary packaging is 
described [44]. In conclusion it can be said that a lot of spectroscopic methods can be used for 
counterfeit detection, but some necessitate expensive and sophisticated equipment. The more 
it has to be said that in general, spectroscopic techniques are used for detection of suspicious 
samples and that they have some disadvantages especially in the detection of impurities and 
the quantification of the active ingredients, since it are often “whole sample” approaches. 
Therefore next to the classical techniques like infrared, chromatographic approaches are 
interesting, since chromatography is a standard technique present in almost all laboratories for 
medicine control.  
 
2.2. Chromatographic approaches 
Chromatographic techniques have been extensively used in the detection and characterisation 
of counterfeit medicines and illegal pharmaceutical preparations. In the majority of the papers 
published, the chromatographic techniques were used for the separation of active ingredients 
in the samples, to quantify them or to isolate the active ingredients and detect or identify with 
e.g. mass spectrometry. In some papers and especially in papers concerning the counterfeit or 
falsification of Traditional Chinese Herbal medicines the use of chromatographic fingerprints 
is well described.  
Different chromatographic techniques were described for the analysis of counterfeit 
medicines and illegal pharmaceutical preparations. 
  
2.2.1. Thin Layer Chromatography 
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Thin layer chromatography (TLC) is a technique that has the advantages to be easy to 
implement and to be cheap. The principle of using TLC in counterfeit analysis is quite simple: 
the presence/identity of the active substance in a counterfeit or imitation sample is confirmed 
by comparing the results with a standard solution which is also applied to a TLC Silica plate.  
TLC was used for the identification of essential drugs, like acetylsalicylic acid, paracetamol, 
ibuprofen, dexamethasone, prednisolone, hydrocortisone,… in preparations and for the 
identification of betamethasone, metamizol and hydrocortisone acetate [79]. TLC combined 
with UV detection and microcrystal tests was used for the detection and identification 
phentermine (Ionamin
®
) adulteration. The results showed that the counterfeit capsules 
contained only caffeine and phenylpropanolamine [80]. More recently Hu et al. [81] 
developed a Fast Chemical Identification System, consisting of two chemical colour reactions 
and two TLC systems for the characterization of counterfeit or suspected macrolide antibiotic 
preparations. The system is able to distinguish 14-membered and 16-membered macrolides 
based on the colour reactions. The TLC sytems (one for each group) are then used to identify 
the concerned macrolide. Another application was described by Moriyasu et al. [82,83] using 
TLC for the identification of sildenafil adulteration in health foods. TLC was applied to 
commercial health food products. After identification of sildenafil, HPLC-DAD revealed 
doses ranging from 25 to 45 mg sildenafil citrate per tablet or bottle, corresponding to the 
therapeutical doses and so constituting an important health risk. Also Reddy et al. [83,84] 
developed a HPTLC method for the identification and quantification of sildenafil in herbal 
formulations. Shewiyo et al. [85,86] developed and validated normal-phase HPTLC methods 
with densitometric detection for the quality control and the counterfeit detection of co-
trimoxazole tablets and fixed-dose combination tablets of lamivudine, stavudine and 
nevirapine.  
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In the counterfeiting of herbal medicines, where wrong and cheaper herbs are sold in stead of 
the medicinal plant, TLC can be applied as well. An example was described by Wu [87] for 
the identification of the counterfeit of a traditional herbal medicine called Curculigo 
Orchiode. For this purpose TLC and UV-spectrometry was applied next to the classical 
morphology and histology tests. 
Recently TLC played an important role in the basic quality control test performed on anti-
malarian drugs in the Amazon Basin Countries. Together with other basic tests TLC could 
reveal an improvement of the quality of these kind of medicines in these countries over the 
years, starting from the beginning of the quality control program [88]. This is a good example 
how basic quality testing, without very sophisticated techniques, can lead to an improvement 
of the quality of sold medicines and the withdrawal of counterfeit and/or substandard 
medicines from the market. 
 
2.2.2. Liquid chromatography 
Liquid chromatography (LC) is often used in the analysis and the characterisation of 
counterfeit medicines and illegal pharmaceutical preparations. LC, in combination with 
different detectors, is used in this domain for several purposes. The first is as a method for 
target analysis (presence of one or more known compounds) and as a quantification method. 
LC in combination with MS is often used in screening of counterfeit samples, identification of 
ingredients and structure elucidation. Another application of liquid chromatography is the use 
of chromatographic fingerprints, in analogy with the fingerprints obtained with spectroscopic 
techniques like infrared. Chromatographic fingerprints are well described in the quality 
control of herbal products and especially in the discrimination of the plant needed from those 
who are sold as counterfeit or falsifications. 
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2.2.2.1. Liquid Chromatography-Ultra Violet Spectroscopy 
LC with ultraviolet detection (UV) or Diode Array Detection (DAD) is still an important 
technique in the quality control of medicines and the characterisation of illegal 
pharmaceutical preparations. The advantages of the technique are its easiness to apply and to 
interpret and the technique is relatively cheap. The more High Performance LC (HPLC)-
UV/DAD belongs to a standard equipment of a medicine control laboratory and is therefore 
available in the majority of the laboratories. 
In literature several methods are described for the analysis of active ingredients in illegal 
preparations as well as for impurities and not registered analogues. HPLC-UV/DAD was 
extensively used in the detection of counterfeited, imitation and adulterated samples 
containing PDE-5 inhibitors. Nagaraju et al. [89] described a method able to separate and 
quantify sildenafil and its impurities. In a chromatographic run of 15 minutes they were able 
to determine sildenafil and its process related impurities, both in bulk products as in 
pharmaceutical formulations. Park et al. [90] screened 105 counterfeit samples, seized in 
Korea, for the presence of sildenafil and tadalafil using HPLC-UV. The results showed that 
73 of the 105 samples contained sildenafil in doses ranging from 4.3 to 453.2 mg per tablet. 
Seven samples contained tadalafil in doses from 2.2 to 40.4 mg per tablet. The proportion of 
cases of having more than 100 mg sildenafil was 50% and 78% had more than 20 mg of 
tadalafil. The presence of amounts higher than the maximal allowed therapeutic dose is 
worrying and represents a huge risk to the patients. Recently our group developed and 
validated a UHPLC-DAD method for the quantification of the three registered PDE-5 
inhibitors (Sildenafil, Tadalafil and Vardenafil) and seven of the most occurring analogues 
and impurities in counterfeit and imitation samples seized in Belgium. The method is applied 
in routine analysis after confirmation and identification with LC-Mass Spectrometry (MS) 
[91]. The same approach was followed by Gratz et al. [92] who developed a HPLC-UV 
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method for the quantification of the registered PDE-5 inhibitors, after their presence was 
confirmed with LC-MS. This group screened 40 botanical products, from which half were 
tested positive for PDE-5 inhibitors. The majority of the positive samples contained 
therapeutic doses of the active ingredients. Tomic et al. [93] conducted a HPLC-UV analysis 
on a group of erectile dysfunction drugs, seized by the Zagreb city police in Croatia. The 
results showed that even if all samples contained the correct active substance, more than 50% 
of the samples failed the content limits of 95-105%, raising the suspicion of counterfeit. De 
Orsi et al. [94] developed a HPLC-DAD method for the determination of PDE-5 inhibitors, 
testosterone and local anaesthetics in cosmetic creams sold as promising remedies for male 
erectile dysfunction and female genital stimulation. The results showed that in the majority of 
the analysed creams one or more of these substances, prohibited in cosmetics, was present.  In 
India HPLC-DAD was used in a screening of Indian aphrodisiac ayurvedic/herbal healthcare 
products for adulteration with PDE-5 inhibitors [95]. In the study 85 samples of this product, 
well known on the regular market in India, were analysed and only one was tested positive for 
adulteration with sildenafil and this in a therapeutic dose. These results showed the initiation 
of the clandestine activity with a traditional Indian product. The previous two studies [94,95] 
clearly show an advantage of using HPLC over spectroscopic methods, i.e. the application to 
different kind of matrices as tablets, creams and herbal products. Zou et al. [96] applied 
HPLC-DAD in the screening of pre-market capsules and pre-mixed bulk powder for the 
presence of PDE-5 inhibitors and their analogues. Six out of seven samples were tested 
positive for non-approved analogues of sildenafil.  
Also for the characterisation of other types of molecules/preparations HPLC with UV 
detection was applied. For example Amin et al. [97] used HPLC-UV in a quality control study 
of sulphadoxine-pyrimethamine and amodiaquine products in Kenya. These products used in 
the prevention and treatment of malaria are life saving medicines and the presence of 
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counterfeit and substandard medicines on the market constitute a huge health risk. The results 
of the tests showed that about one third of the preparations analysed failed the limits of 93-
107% set by the USP [98]. Gaudiano et al. [99] applied HPLC-DAD for the quality control of 
antimalarial tablets purchased on the informal market of Goma (Democratic Republic of 
Congo). The results showed not only that the tablets contained only 88.6% of the indicated 
amount quinine, but also a high number of impurities in amounts higher than the reference 
samples and the samples purchased on the Italian market. Debrus et al. [100] proposed a 
HPLC-DAD method for the screening of 19 anti-malaria drugs in pharmaceutical 
preparations. The method was validated and intended for the use in developing countries, 
where the anti-malaria drugs are important on the black markets as substandard or counterfeit 
drugs.  
A validated HPLC-DAD method for the simultaneous screening of some antibiotics often 
present in counterfeit and sub-standard medicines was proposed by Gaudiano et al. [101].  
Shad et al. [102] proposed a HPLC-UV method for the characterisation of potential 
counterfeit isometamidium products. Isometamidium is a product used in the prophylaxis of 
veterinary trypanosomiasis.  
Another important problem, especially in the western world are the dietary supplements sold 
for weight control and presumed to be 100% natural and from herbal origin, though 
adulteration with different kinds of synthetic drugs were discovered. Also here HPLC-UV 
was extensively used. Kim et al. [103] developed and validated a LC-DAD method, 
applicable to routine drug-adulteration screening of dietary supplements for anti-diabetes and 
anti-obesity drugs. This kind of screening is very important, especially in the western world 
were adulterated dietary supplements, purchased via internet are one of the major groups of 
preparations seized and analysed. Dietary supplements adulterated with sibutramine and its 
analogues are encountered frequently. Stypulkowska et al. [104] proposed a strategy for the 
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characterisations of such adulterated supplements in which first the presence of a chemical is 
tested with X-ray powder diffraction, followed by an identification of sibutramine and/or its 
analogues with XRPD and/or LC-Time of Flight (TOF)-MS. LC-UV is used to quantify 
sibutramine and/or its analogues when their presence and identity is confirmed. Other 
examples of applications are given by Almeida et al. [105,106], who proposed HPLC-UV 
methods for the confirmation and quantification of amfepramone, fenproporex, diazepam and 
mazindol as adulterants in herbal preparations. Mikami et al. [107] proposed a HPLC-UV 
method for the screening of benzodiazepines in herbal slimming products. Benzodiazepines 
are often used to mask the side effects of anorexics. Recently our group developed and 
validated a UHPLC-DAD method for the simultaneous quantification of nine chemical 
compounds (Sibutramine, modafinil, metformine, orlistat, diethylpropion, ephedrine, nor-
ephedrine, caffeine and theophyllin), often encountered in adulterated herbal dietary 
supplements with slimming as indication [108]. Liu et al. [109] described a HPLC-DAD 
method that, in combination with a GC-MS method is able to screen herbal dietary 
supplements for adulteration with 266 pharmaceuticals.  
 
2.2.2.2. Liquid Chromatography-Mass Spectroscopy 
Liquid chromatography coupled to mass spectrometry is the method of choice when dealing 
with counterfeit and illegal pharmaceutical preparations. The method not only allows target 
analysis, but also screening of unknown preparations for the presence of chemical drug 
compounds. The more, when an unknown compound is encountered, LC-MS in combination 
with other techniques like IR and NMR, allows identification and/or structure elucidation. 
The latter is very important since the companies producing counterfeit medicines and 
imitations are modifying the chemical structure of the registered active substances, creating 
non-tested analogues in order to avoid patent laws.   
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In both domains, LC-MS as screening method and LC-MS for structure elucidation, numerous 
papers were published.  
In the group of the PDE- inhibitors a lot of not registered analogues and impurities were yet 
detected. The majority was detected and identified using LC-MS, generally combined with 
NMR and IR techniques [28,29,50-74]. An overview of the different analogues yet detected 
over the years was recently given by Venhuis et de Kaste [26], therefore this applications will 
not be discussed in detail here. Next to the use of LC-MS in the structure elucidation of 
analogues and impurities, several screening methods for the detection and identification of 
PDE-5 inhibitors, their analogues and impurities were described [92,96,110-112]. 
Even if the highest numbers of papers using LC-MS for screening and structure elucidation in 
the domain of counterfeiting medicines deal with the PDE-5 inhibitors, also other 
counterfeited medicines can be analysed with LC-MS. Amin et al. [97] used LC-MS in 
quality control and the detection of counterfeit and substandard sulphadoxine-pyrimethamine 
and amiodiaquine products. Li et al. [113] performed the structural elucidation of dapoxetine, 
a selective serotonin reuptake inhibitor, present as adulterant in a health supplement for sexual 
performance enhancement. Recently Dorlo et al. [114] applied LC-MS, combined with FT-IR 
and NIR, for the detection of counterfeit miltefosine capsules, used to treat a fatal parasitic 
disease in resource poor countries. Dai et al. [115] developed a UHPLC-MS method for the 
qualitative detection of alpha-glucosidase inhibitors in potential counterfeit products, sold to 
treat diabetes. 
A group of medicines often encountered as adulterants in herbal slimming preparations are 
the anti-obesity drugs like sibutramine and analogues, but also other anorexics as well as 
diuretics, antidepressants and laxative molecules [116].  Also here LC-MS was applied both 
for screening as for identification purposes. Both Kim et al. [103] as Stypulkowka et al. [104] 
applied LC-MS for the screening of herbal dietary supplements for the presence of 
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sibutramine and its analogues. Venhuis et al. [117] applied LC-MS in the identification of 
rimonabant and sibutramine and their analogues in counterfeit Acomplia and imitation 
products while Wang et al. [118] used LC-MS to perform a survey of 22 herbal weight 
reducing preparations for the presence of sibutramine and its analogues, phenolphthalein, 
fenfluramine and orlistat. Out of the 22 samples, 10 were positive for sibutramine, 3 for 
phenolphtaleine and 2 contained N-mono-desmethyl sibutramine. 
Bogusz et al. [119] developed a LC-MS/MS method to screen herbal remedies for the 
presence of synthetic adulterants. The proposed method was able to screen for adulterants of 
different clinical groups, comprising analgesic drugs, antibiotics, antidiabetic drugs, 
antiepileptic drugs, aphrodisiacs, hormones and anabolic drugs, psychotropic drugs and 
weight reducing compounds. A similar approach was followed by Chen et al. [120], who 
developed a LC-QTRAP-MS method to screen botanical health supplements for the presence 
of blood pressure and lipid lowering agents, sedative drugs, anti-diabetic drugs, weight 
reducing agents and aphrodisiac drugs. De Carvalho et al. [121] recently reviewed all the 
compounds found as adulterants in slimming phytotherapeutic formulations as well as their 
analytical approaches. The majority of the different groups of adulterants can be screened for 
with LC-MS and comprises anorexics, diuretics, benzodiazepines, antidepressants, analgesics, 
hypoglycemics,…. 
Another application was given by Hall et al. [122], who applied LC-MS for the 
characterisation of artesunate tablets purchased in different Asian countries; 23 of 34 samples 
did not contain artesunate; 10 of the 11 that did contained artesunate in the correct dose. From 
the 23 samples, not containing artesunate eight contained erythromycin and five paracetamol. 
 
2.2.2.3. Chromatographic fingerprinting 
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Chromatographic fingerprinting is a technique that is extensively described in the domain of 
plant analysis and in specific for authentic species recognition of traditional herbal medicines. 
A fingerprint can be defined as a characteristic profile reflecting the (complex) chemical 
composition of the analysed sample and can be obtained by spectroscopic, chromatographic 
and electrophoretic techniques [123,124]. Spectroscopic fingerprints are very interesting and 
widely used for the identification of bulk materials. Pharmacopoeias use infrared spectra to 
compare the “fingerprint” regions of the spectra obtained from a sample with a reference 
spectra, identifying a bulk product as the concerned drug compound [98,125,126]. As 
described above infrared spectroscopy and other spectroscopic techniques have already 
proven to be very valuable in the analysis and the discrimination of counterfeit medicines. 
Nevertheless a disadvantage of spectroscopic fingerprints is the fact that the fingerprint is 
influenced by all compounds of the samples, since it is a whole sample analysis. 
Therefore fingerprints based on separation techniques like chromatography and 
electrophoresis are very interesting. By spreading the information about the chemical 
composition of the sample over time, the individual compounds and their underlying 
information can be revealed [123,124]. Chromatographic fingerprinting is mostly used in 
plant analysis and this for several purposes: for classification of plants, especially to 
differentiate related species, who’s minor differences in composition can largely affect the 
public health [128-130], for stability testing and quality control [130,131] and to predict 
pharmacological activities or to identify potential active compounds [132-136].  The first 
application is the one that is interesting in the detection and characterisation of counterfeit 
samples. Also in herbal medicines counterfeiting is occurring selling non standardized, related 
plants or even totally different plants, with huge health risks as a consequence.  
Even if TLC [136-147] and GC-MS [148-159] (essentially for essential oils) are techniques 
that proved their usefulness in the identification of plants and the discrimination between 
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species, the literature is more and more turning to liquid chromatography combined with 
different detectors to differentiate between plants and so fighting counterfeits. The advantages 
of HPLC are the easiness to operate, the fully automatable character and the high resolution, 
selectivity and sensitivity. For herbal fingerprinting, many papers were published using UV 
absorbance as detection [160-174], ELSD [162,170], chemiluminescence detection and mass 
spectrometry [160,164,166,169,175,176].  
Despite the potential of chromatographic fingerprints in the classification, identification and 
discrimination of herbs and traditional medicines, only few publications using them in the 
domain of counterfeit medicines were published. Dumarey et al. [177] used chromatographic 
fingerprints or impurity profiles to distinguish four clusters of paracetamol preparations based 
on their synthesis pathways. In fact paracetamol can be synthesised in different ways and each 
synthesis pathway has its own impurity profile. This approach can both be used for detecting 
patent infringements as for counterfeit identification, since both synthesis pathways as the 
amounts of impurities can differ between genuine and counterfeit/imitation medicines. 
Schneider and Wessjohann compared the impurity profiles of Orlistat pharmaceutical 
products [178]. The impurity profiles recorded both with LC-UV as LC-MS/MS showed a 
clear difference between the original product (Xenical
®
) and two generic (legal) products 
(Figure 3). Even if the major impurity was the same for the three products, the generic 
products contained respectively 17 and 14 different impurities above the detection limit 
compared to 4 for the original product. All impurities were well within quality limits, so no 
problem is to be expected with the generic products, but this study shows that impurity 
profiles or fingerprints can be used to discriminate between original and generic products. 
Since the discrimination between original and generic is often more difficult than the 
discrimination between counterfeit and genuine, the approach will also be valuable in the 
detection and discrimination of counterfeit or imitation products of Xenical
®
. Indeed generic 
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products have to meet the same quality requirements as the original products, where 
counterfeits and imitation often do not meet those requirements. These two studies illustrate 
the possibilities and the potential of chromatographic fingerprints in counterfeit detection. Our 
group conducted a feasibility study for the use of such fingerprints for the discrimination 
between genuine and counterfeit medicines. Two case studies were studied: one for a set of 73 
counterfeit and imitation and 9 genuine samples of Viagra
®
 and one for a set of 44 counterfeit 
and imitation and 5 genuine samples of Cialis
®
 [179]. The fingerprints were recorded using 
HPLC-UV with adapted methods from the ones published in Pharmeuropa [180,181]. The 
fingerprints or impurity profiles showed clear differences between the genuine and 
counterfeit/imitation samples as can be deduced from figure 4. The results showed, as could 
be already concluded from the studies in [177,178], that it is possible to discriminate 
counterfeits and genuine based on chromatographic fingerprints or impurity profiles.  
A disadvantage of the chromatographic fingerprint approach is the difficulty to extract the 
information from the data. In general chemometrics are necessary to handle the amounts of 
data generated, especially for large sample sets. When recording chromatographic fingerprints 
or impurity profiles, retention time shifts can occur under the influence of column ageing, 
temperature changes and mobile phase changes. These shifts influence the data analysis and 
interpretation and therefore the chromatograms should be aligned or warped. Different 
allignement or warping techniques exists [124,179,182,183]. The most popular technique is 
correlation optimized warping (COW) [124,182,183]. Next to the problem of data pre-
treatment, chromatographic techniques applied for fingerprinting generate high amounts of 
data, which causes the problem of interpretability. Again chemometric approaches are 
necessary to interpret the data and to differentiate different samples, as genuine and 
counterfeits. In chromatographic fingerprinting and more specific in the discrimination 
between samples Principal Component Analysis (PCA), Partial Least Squares (PLS) and 
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clustering techniques are often used [124,179]. Only few papers used modelling techniques in 
order to be able to predict the nature of a sample based on its chromatographic fingerprint. As 
modelling techniques basic techniques as k-Nearest Neighbours (k-NN) and Soft Independent 
Modelling by Class Analogy (SIMCA), seems to work perfectly for the discrimination 
between counterfeit and genuine samples [179,184]. Our group recently showed that some 
more advanced chemometrics can be valuable in the discrimination of genuine and counterfeit 
samples based on chromatographic fingerprints and more specific in the differentiation 
between the different classes/groups of counterfeit samples [184]. 
 
2.2.3. Gas chromatography 
Also Gas Chromatographic (GC) techniques were used in the detection and the 
characterisation of counterfeit medicines. Gas chromatography was used to confirm the 
identity of essential oils, the presence of residual solvents, volatile constituents (especially in 
the quality control of herbal medicines) and unknown compounds or analogues [185]. Two 
examples of the latter are the detection of amphetamine in stead of sildenafil citrate with GC-
MS in counterfeited tablets of Viagra
®
 in Hungary [4,186] and  the detection of oxycodone 
and dihydrocodeinone in counterfeit Ritalin
®
  with GC-Flame Ionisation Detection and GC-
MS [187]. Reepmeyer et al. [2,57] used chemical derivatization and GC-MS to differentiate 
the four different possible structures of piperidenafil. To resolve the structure, the presence of 
the piperidine moiety was confirmed with acid hydrolysis of the sulphonamide bond, 
followed by analysis of the amine and the sulfonic acid by GC-MS. The same approach was 
used to elucidate structures of nor-acetildenafil [2,57] and aildenafil [188]. Liu et al. [109] 
proposed a GC-MS screening method, which, in combination with LC-DAD, is able to screen 
for 266 pharmaceuticals present as adulteration in herbal preparations. Among these 
pharmaceuticals are the important groups of anorexics, anxioletics, antidepressants and 
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diuretics, often found in so called natural slimming products. A German group analysed 42 
products of anabolic steroids from the illegal German market with GC-MS and found that 15 
of these products did not contain the compounds that were labelled [189]. This is an example 
of the performance of GC-MS for the analysis of steroids. In fact this is the major application 
of GC-MS in the analysis of illegal pharmaceutical preparations in medicine control 
laboratories. 
Lin et al. [190] used GC-MS in a study about counterfeiting of musk, a highly valued 
ingredient in Chinese Traditional Medicines, and found that no muscone, the compound 
believed to be the active ingredient was present in products seized by the customs or in Musk-
Tiger Bone plaster preparations. On the contrary muscone was clearly present in the 
preparations purchased in the Chinese medicines stores. 
In Iran GC-MS and HPLC was used in the analysis of counterfeit preparations of 




, one of the most popular 
drugs of abuse by the young opioid-addicted population in Iran. Researchers revealed the 
presence of diacetylmorphine, acetylcodeine and pheniramine in stead of buprenorphine in the 
majority of the samples originating from the black market [191]. In Jordan GC-MS was 
applied in the screening of seized counterfeit Captagon
®
 tablets (fenethylline), a popular drug 
of abuse in the Middle-East. The results revealed the presence of amphetamine and 
methamphetamine, responsible for the stimulant effect experienced by the abuser, but also 
different other compounds like anti-malarial drugs, antibiotics, sympaticomimetica,…. The 
presence of these compounds in these preparations represent huge health risks, especially 
since they are often present in combination with fenethylline and that the interactions between 
these drugs are unknown [192]. Lee et al. [193] used impurity profiles, recorded with GC-FID 
and GC-MS, of illicit methamphetamine seized in Japan and Korea as chemical fingerprints to 
cluster samples with possibly the same origin. The study revealed similarities between 
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samples seized in different regions of Japan and Korea, showing the international nature of 
the trade in methamphetamine.   
The analysis of organic volatile impurities is a useful tool in the quality control of bulk 
pharmaceuticals and allows also the detection of counterfeit drugs and even tracing their 
source. Static headspace analysis in combination with GC-MS is often used in the detection of 
organic volatile impurities, e.g. residual solvents [194-199]. This approach was used 
successfully in the detection of counterfeit sulfamethazine, ranitidine hydrochloride and 
doxycycline hyclate [200]. In each case the different sources could be distinguished based on 
the profile of the organic volatile impurities present. Recently our group conducted a study in 
which a group of counterfeit and imitation Viagra
®
 and a group of counterfeit and imitation 
Cialis
®
 samples were tested for their residual solvent content [201]. The content was 
compared to the residual solvent content of the respective genuine products and revealed a 
clear difference between genuine and counterfeit/imitation samples. In the non genuine 
samples more residual solvents were present and in higher doses, often in amounts exceeding 
the limits as set by the International Committee for Harmonisation guideline for residual 
solvents [202] and the Pharmacopoeia’s [98,125,126]. 
 
 2.3. electrophoretic approaches 
Electrophoresis is another separation technique that was described for some applications in 
the analysis of counterfeit medicines, substandard medicines and adulterated herbal 
preparations. Capillary electrophoresis (CE) has some advantages like the high resolution 
power (selectivity), short analysis time and the low consumption of chemicals and samples. 
Marini et al. [203] developed and validated methods for a prototype of a portable CE device, 
based on capillary zone electrophoresis (CZE) for the quantification of some important 
antimalarial drugs for quality control and counterfeit detection. The idea is to apply this 
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device and the corresponding methods as quality control device in some African regions were 
counterfeiting is reaching high proportions. Recently Amin et al. [204] proposed a CE method 
for the quality control of fixed dose combination tablets of artesunate and amodiaquine. Also 
here the authors considered the advantages of CE (long lifetime, low price of capillaries, low 
volumes and simplicity) over HPLC in the fight against low quality medicines in developing 
countries. Recently Lamalle et al. [205] proposed a Micellar Electrokinetic Chromatography 
(MEKZ) method to detect and quantify 15 antimalarial drugs in pharmaceutical preparations. 
The method was applied to four pharmaceutical preparations purchased on the African 
market. The results showed that all preparations contained the correct ingredients, though 
three of the four did not meet the 95-105% content limits set by the pharmacopoeia’s and two 
of them contained the active ingredients in a dose inferior to 90% of the one claimed on the 
package.  
Another domain in which CE was applied was in the determination of adulterants in herbal 
preparations. The most frequently used techniques are CZE and MEKZ. CZE methods were 
proposed for the determination of anorexics [206,207], amphetamines [206,208], 
benzodiazepines [207] and some other frequently found adulterants [206,207,209]. MEKZ 
methods were proposed for benzodiazepines [210,211,212] and nortriptyline, sulpiride and 
pyridoxine [211]. The use of CE in the domain of counterfeit medicines is not well described 
in literature, as is the same for the use of CE-MS, that could have a potential as confirmation 
method for adulterants.  
 
3. Discussion and conclusion 
The idea of this review was to give a general overview of the role chromatography plays 
nowadays in the detection, the analysis/characterisation and the risk assessment of illegal and 
counterfeited pharmaceutical preparations. In literature the spectroscopic techniques and 
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especially NIR and Raman spectroscopy are still very popular in the detection of 
counterfeited and illegal preparations. The spectroscopic methods surely have a lot of 
advantages especially for the detection of counterfeit medicines, where the spectrum of a 
sample can be compared to the one of the genuine product. Though in the analysis of illegal 
pharmaceutical preparations, like imitated medicines or adulterated dietary supplements these 
methods have the disadvantage of being a whole sample approach. For the detection of a 
chemical compound in a matrix and especially in an herbal matrix with spectroscopy, the 
compound should be present in a considerable dose and no masking effects from matrix 
compounds should occur. If this is not the case, it is possible to classify a sample as legal and 
safe based on the spectroscopic results alone, especially when the sample is not send to a 
laboratory, but screened with a portable device by the customs. The more, in the case of 
adulterated dietary supplements, it is not unthinkable that illicit producers add components to 
the matrix in order to mask the synthetic compounds from detection with spectroscopy. 
These disadvantages of the spectroscopic techniques can be solved by applying separation 
methods as chromatography. Here the synthetic compounds are first extracted from the matrix 
and secondly separated on the TLC plate, chromatographic column or capillary, depending of 
the technique chosen. After separation the components are detected separately, identified and 
if wanted quantified. When an unknown component is detected, mass spectrometry and 
spectroscopic techniques (FT-IR, NMR) can be applied for structure elucidation.   
Another field in which separation methods and especially chromatography has to be preferred 
over spectroscopic methods is the field of health sciences. In this domain it is not enough to 
divide samples in counterfeit and genuine, but they should also be evaluated for the risk they 
represent to the patient or in general to public health. In this case chromatographic 
fingerprinting can be of interest, since it does not only allow identifying and quantifying the 
active ingredients and detecting counterfeit products, it also gives a complete image of the 
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product. A lot of impurities in the fingerprint, means, in comparison with the genuine, that it 
is a counterfeit and one of low quality and so potentially dangerous. The more a 
chromatographic fingerprint can reveal the presence of a chemical substance (concentration 
>0.1%) in a dietary supplement, presumed to be of herbal origin.  
In conclusion it can be said that all techniques, spectroscopic and chromatographic, have their 
use in the detection and analysis of illegal pharmaceutical preparations, depending on the 
purpose of the study. For simple counterfeit detection spectroscopic methods are very useful, 
but they have some disadvantages in the detection of adulterations and the evaluation of the 
risk for public health. Separation techniques have the advantage to enable a complete analysis 
of the sample: detection/identification of active substances, classification as counterfeit, 
imitation or genuine and risk evaluation. The disadvantage is the limited possibilities for 
miniaturization and application in portable devices. 
In general it can be concluded that authorities, health practitioners and patients should be 
vigilant. Despite the initiatives concerning tampering, holograms and other to protect the legal 
supply chain, the presence of counterfeited products can not entirely be excluded. The more 
the patients should be aware that buying medicines or dietary supplements via internet or 
from an illegal source can seriously endanger their health.  
Unfortunately the literature discussing or reporting incidents of counterfeit medicines, 
imitations or adulterated dietary supplements are only showing the tip of the iceberg. 
Therefore the development of efficient analytical methods for detection, characterization and 
risk evaluation should continue and probably their use and necessity will not diminish in the 
near future. Analytical results concerning these products are necessary to support the health 
authorities in their decisions and prevention campaigns, but also as part of legal dossiers for 
pharmaceutical crime.    
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Figure captions: 
Figure 1: Total number of reports of counterfeiting, illegal diversion and theft incidents for 
nine consecutive years [6]. 
Figure 2: Counterfeit drug cases opened by the FDA’s office of criminal investigation per 
fiscal year.  
Figure 3: HPLC-UV chromatograms of samples of Roche A: (Xenical
®
 – blue line), Ranbaxy 
B: (Cobese™ – red line) and KRKA C: (Orsoten – green line) tetrahydrolipstatin drugs 
(Reprinted with permission from [178]) 
Figure 4: A. Impurity profile of a counterfeit tablet of Viagra
®
. B. Impurity profile of a 
genuine tablet of Viagra
®
. C. Impurity profile of a coloured imitation tablet of Cialis
®
. D. 
Impurity profile of a genuine tablet of Cialis
® 
(Reprinted with permission from [179]).  
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Table 1: Definition of the RIVM classes [13]  
Main 
category Subcategory Inclusion and exclusion criteria 
  Professional Appearance in conformity with genuine medicine; 
    Content of correct API within 90 - 110 % of declared value; 
    No other APIs; not genuine medicine. 
  Non-professional Appearance in conformity with genuine medicine; 
    Content of correct API outside 90 - 110 % of declared value; 
    No other APIs. 
Counterfeit Mixed  Appearance in conformity with genuine medicine; 
   Contains correct API and another, known API  
  Fraudulent  Appearance in conformity with genuine medicine; 
    Contains a different, known API.  
  Analog  Appearance in conformity with genuine medicine, 
    Contains other, unapproved API  
  Placebo Appearance in conformity with genuine medicine; 
    Does not contain APIs.  
  Professional Appearance not in conformity with genuine medicine; 
    Content of correct API within 90 - 110 % of declared value; 
    No other APIs. 
  Non-professional Appearance not in conformity with genuine medicine; 
    Content of declared API outside 90 - 110 % of declared value; 
    No other APIs. 
Imitation Mixed  Appearance not in conformity with genuine medicine; 
   Contains declared API and another API. 
  Fraudulent  Appearance not in conformity with genuine medicine; 
    Contains an undeclared API. 
  Analog  Appearance not in conformity with genuine medicine; 
    Contains other, unapproved API  
  Placebo Appearance not in conformity with genuine medicine; 
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